139 related articles for article (PubMed ID: 29074487)
21. Ferulic Acid Exerts Anti-Angiogenic and Anti-Tumor Activity by Targeting Fibroblast Growth Factor Receptor 1-Mediated Angiogenesis.
Yang GW; Jiang JS; Lu WQ
Int J Mol Sci; 2015 Oct; 16(10):24011-31. PubMed ID: 26473837
[TBL] [Abstract][Full Text] [Related]
22. Platelet-derived growth factor (PDGF) induces pulmonary vascular remodeling through 15-LO/15-HETE pathway under hypoxic condition.
Zhang L; Ma J; Shen T; Wang S; Ma C; Liu Y; Ran Y; Wang L; Liu L; Zhu D
Cell Signal; 2012 Oct; 24(10):1931-9. PubMed ID: 22735810
[TBL] [Abstract][Full Text] [Related]
23. Magnolol suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting Ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways.
Kim KM; Kim NS; Kim J; Park JS; Yi JM; Lee J; Bang OS
Nutr Cancer; 2013; 65(8):1245-53. PubMed ID: 24066970
[TBL] [Abstract][Full Text] [Related]
24. TGF-β1 inhibits the apoptosis of pulmonary arterial smooth muscle cells and contributes to pulmonary vascular medial thickening via the PI3K/Akt pathway.
Li L; Zhang X; Li X; Lv C; Yu H; Xu M; Zhang M; Fu Y; Meng H; Zhou J
Mol Med Rep; 2016 Mar; 13(3):2751-6. PubMed ID: 26861477
[TBL] [Abstract][Full Text] [Related]
25. Eicosanoid regulation of angiogenesis: role of endothelial arachidonate 12-lipoxygenase.
Nie D; Tang K; Diglio C; Honn KV
Blood; 2000 Apr; 95(7):2304-11. PubMed ID: 10733500
[TBL] [Abstract][Full Text] [Related]
26. 20-HETE increases survival and decreases apoptosis in pulmonary arteries and pulmonary artery endothelial cells.
Dhanasekaran A; Bodiga S; Gruenloh S; Gao Y; Dunn L; Falck JR; Buonaccorsi JN; Medhora M; Jacobs ER
Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H777-86. PubMed ID: 19136601
[TBL] [Abstract][Full Text] [Related]
27. Pigment epithelium-derived factor inhibits retinal microvascular dysfunction induced by 12/15-lipoxygenase-derived eicosanoids.
Ibrahim AS; Tawfik AM; Hussein KA; Elshafey S; Markand S; Rizk N; Duh EJ; Smith SB; Al-Shabrawey M
Biochim Biophys Acta; 2015 Mar; 1851(3):290-8. PubMed ID: 25562624
[TBL] [Abstract][Full Text] [Related]
28. Targeting Endothelial ENO1 (Alpha-Enolase) -PI3K-Akt-mTOR Axis Alleviates Hypoxic Pulmonary Hypertension.
Shi Y; Liu J; Zhang R; Zhang M; Cui H; Wang L; Cui Y; Wang W; Sun Y; Wang C
Hypertension; 2023 May; 80(5):1035-1047. PubMed ID: 37075135
[TBL] [Abstract][Full Text] [Related]
29. Vasculoprotective effect of U50,488H in rats exposed to chronic hypoxia: role of Akt-stimulated NO production.
Li J; Shi QX; Fan R; Zhang LJ; Zhang SM; Guo HT; Wang YM; Kaye AJ; Kaye AD; Bueno FR; Xu XZ; Yu SQ; Yi DH; Pei JM
J Appl Physiol (1985); 2013 Jan; 114(2):238-44. PubMed ID: 23139366
[TBL] [Abstract][Full Text] [Related]
30. Acetylated cyclophilin A is a major mediator in hypoxia-induced autophagy and pulmonary vascular angiogenesis.
Mao M; Yu X; Ge X; Gu R; Li Q; Song S; Zheng X; Shen T; Li X; Fu Y; Li J; Zhu D
J Hypertens; 2017 Apr; 35(4):798-809. PubMed ID: 28079595
[TBL] [Abstract][Full Text] [Related]
31. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway.
Jung KH; Choi MJ; Hong S; Lee H; Hong SW; Zheng HM; Lee HS; Hong S; Hong SS
Cancer Lett; 2012 Mar; 316(2):187-95. PubMed ID: 22182943
[TBL] [Abstract][Full Text] [Related]
32. CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation.
Nie X; Tan J; Dai Y; Liu Y; Zou J; Sun J; Ye S; Shen C; Fan L; Chen J; Bian JS
J Mol Cell Cardiol; 2018 Mar; 116():41-56. PubMed ID: 29374556
[TBL] [Abstract][Full Text] [Related]
33. 15-lipoxygenase-1/15-hydroxyeicosatetraenoic acid promotes hepatocellular cancer cells growth through protein kinase B and heat shock protein 90 complex activation.
Ma J; Zhang L; Zhang J; Liu M; Wei L; Shen T; Ma C; Wang Y; Chen Y; Zhu D
Int J Biochem Cell Biol; 2013 Jun; 45(6):1031-41. PubMed ID: 23474367
[TBL] [Abstract][Full Text] [Related]
34. [Role of 15-lipoxygenase/15-hydroxyeicosatetraenoic acid in hypoxic pulmonary arterial hypertension].
Yu H; Ma C; Zhu DL
Sheng Li Xue Bao; 2021 Aug; 73(4):646-656. PubMed ID: 34405220
[TBL] [Abstract][Full Text] [Related]
35. 15(S)-hydroxyeicosatetraenoic acid induces angiogenesis via activation of PI3K-Akt-mTOR-S6K1 signaling.
Zhang B; Cao H; Rao GN
Cancer Res; 2005 Aug; 65(16):7283-91. PubMed ID: 16103079
[TBL] [Abstract][Full Text] [Related]
36. Role of 15-lipoxygenase/15-hydroxyeicosatetraenoic acid in hypoxia-induced pulmonary hypertension.
Zhu D; Ran Y
J Physiol Sci; 2012 May; 62(3):163-72. PubMed ID: 22331435
[TBL] [Abstract][Full Text] [Related]
37. Preventive effect of LCZ696 on hypoxic pulmonary hypertension in rats via regulating the PI3K/AKT signaling pathway.
Wang J; Ma YR; Chang YE; Duo DL; Duan KK; Zhao N; Cui WL; Huan ZL; Wang YF
Pulm Pharmacol Ther; 2023 Oct; 82():102229. PubMed ID: 37355202
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of CXCL12/CXCR4 suppresses pulmonary arterial smooth muscle cell proliferation and cell cycle progression via PI3K/Akt pathway under hypoxia.
Wei L; Zhang B; Cao W; Xing H; Yu X; Zhu D
J Recept Signal Transduct Res; 2015; 35(4):329-39. PubMed ID: 25421526
[TBL] [Abstract][Full Text] [Related]
39. 15-Lipoxygenase promotes chronic hypoxia-induced pulmonary artery inflammation via positive interaction with nuclear factor-κB.
Li J; Rao J; Liu Y; Cao Y; Zhang Y; Zhang Q; Zhu D
Arterioscler Thromb Vasc Biol; 2013 May; 33(5):971-9. PubMed ID: 23493287
[TBL] [Abstract][Full Text] [Related]
40. Euscaphic acid and Tormentic acid protect vascular endothelial cells against hypoxia-induced apoptosis via PI3K/AKT or ERK 1/2 signaling pathway.
Shi C; Li Z; Wu Y; Li X; Li Y; Wei J; Li J; Zhang Y; Li L
Life Sci; 2020 Jul; 252():117666. PubMed ID: 32298737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
